{"id":"https://openalex.org/W149195136","doi":null,"title":"Efficacy of cabergoline on rapid escalation of dose in men with macroprolactinomas.","display_name":"Efficacy of cabergoline on rapid escalation of dose in men with macroprolactinomas.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W149195136","mag":"149195136","pmid":"https://pubmed.ncbi.nlm.nih.gov/20424304"},"language":"en","primary_location":{"id":"pmid:20424304","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20424304","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Indian journal of medical research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W149195136"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060183060","display_name":"Anil Kumar Bhansali","orcid":"https://orcid.org/0000-0003-3621-4337","observed_orcids":["https://orcid.org/0000-0003-3621-4337"]},"institutions":[{"id":"https://openalex.org/I45294948","display_name":"Post Graduate Institute of Medical Education and Research","ror":"https://ror.org/009nfym65","country_code":"IN","type":"education","lineage":["https://openalex.org/I45294948"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Bhansali","raw_affiliation_strings":["Departments of Endocrinology, Postgraduate Institute of Medical Education & Research Chandigarh, India. anilbhansali_endocrine@rediffmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Endocrinology, Postgraduate Institute of Medical Education & Research Chandigarh, India. anilbhansali_endocrine@rediffmail.com","institution_ids":["https://openalex.org/I45294948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008804538","display_name":"Rama Walia","orcid":"https://orcid.org/0000-0002-6633-923X","observed_orcids":["https://orcid.org/0000-0002-6633-923X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R Walia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056163184","display_name":"Pinaki R Dutta","orcid":"https://orcid.org/0000-0001-5415-1611","observed_orcids":["https://orcid.org/0000-0001-5415-1611","https://orcid.org/0000-0002-8104-8000"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Dutta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111657980","display_name":"Niranjan Khandelwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N Khandelwal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113519072","display_name":"R Sialy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R Sialy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002673886","display_name":"Sanjay Kumar Bhadada","orcid":"https://orcid.org/0000-0002-0410-8778","observed_orcids":["https://orcid.org/0000-0002-0410-8778"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S Bhadada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0696,"has_fulltext":false,"cited_by_count":19,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.76728739,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"131","issue":null,"first_page":"530","last_page":"535"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabergoline","display_name":"cabergoline","score":0.9549999833106995},{"id":"https://openalex.org/keywords/macroprolactinoma","display_name":"macroprolactinoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/dopamine-agonist-therapy","display_name":"dopamine agonist therapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/tumor-shrinkage","display_name":"tumor shrinkage","score":0.8339999914169312},{"id":"https://openalex.org/keywords/visual-field-defects","display_name":"visual field defects","score":0.9520000219345093},{"id":"https://openalex.org/keywords/testosterone-levels","display_name":"testosterone levels","score":0.6480000019073486},{"id":"https://openalex.org/keywords/men","display_name":"men","score":0.39800000190734863},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6460000276565552},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.597000002861023},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-occupancy","display_name":"dopamine D2 receptor occupancy","score":0.4690000116825104},{"id":"https://openalex.org/keywords/anterior-pituitary-adenoma","display_name":"anterior pituitary adenoma","score":0.703000009059906},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.49799999594688416},{"id":"https://openalex.org/keywords/hypogonadism","display_name":"hypogonadism","score":0.609000027179718},{"id":"https://openalex.org/keywords/growth-rate","display_name":"growth rate","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C2779832395","wikidata":"https://www.wikidata.org/wiki/Q423308","display_name":"Cabergoline","level":4,"score":0.9926847219467163},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.795162558555603},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.7180618047714233},{"id":"https://openalex.org/C2778918492","wikidata":"https://www.wikidata.org/wiki/Q954831","display_name":"Prolactinoma","level":4,"score":0.5312250256538391},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4431101679801941},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4383698105812073},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3577222228050232},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.26574593782424927}],"mesh":[{"descriptor_ui":"D000077465","descriptor_name":"Cabergoline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015175","descriptor_name":"Prolactinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:20424304","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20424304","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Indian journal of medical research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1573258339","https://openalex.org/W1998980446","https://openalex.org/W2007081090","https://openalex.org/W2018722598","https://openalex.org/W2049638429","https://openalex.org/W2055052077","https://openalex.org/W2064053223","https://openalex.org/W2067202852","https://openalex.org/W2074337014","https://openalex.org/W2091047975","https://openalex.org/W2115298713","https://openalex.org/W2121137604","https://openalex.org/W2157061317","https://openalex.org/W2161513867","https://openalex.org/W2171791848","https://openalex.org/W2408462835"],"related_works":["https://openalex.org/W2516580549","https://openalex.org/W1507784367","https://openalex.org/W2049638429","https://openalex.org/W15060623","https://openalex.org/W2171791848","https://openalex.org/W2154895266","https://openalex.org/W2091047975","https://openalex.org/W3174849458","https://openalex.org/W2007081090"],"abstract_inverted_index":{"BACKGROUND":[0],"&":[1,358],"OBJECTIVES:":[2],"Since":[3],"cabergoline":[4,58,95,215,231,313,332,355,368],"has":[5],"a":[6,111,184,234,406],"long":[7],"half-life":[8],"and":[9,38,52,83,90,99,119,165,253,281,299,325,334,387,390,410],"sustained":[10],"occupancy":[11],"of":[12,35,54,57,79,94,113,156,167,187,196,214,225,230,261,312,331,340,354,367,377,384],"dopamine":[13],"(D2)":[14],"receptors":[15],"in":[16,32,41,60,145,222,237,257,268,274,296,321,337,379,392,399],"lactotrophs,":[17],"its":[18,371,397],"doses":[19,59,146,369],"are":[20],"slowly":[21],"built":[22],"up":[23],"either":[24],"monthly":[25,105],"or":[26],"two":[27],"monthly.":[28],"This":[29,44],"possibly":[30],"results":[31],"delayed":[33],"normalization":[34,383],"serum":[36,238,385],"prolactin":[37,98,175,239,386],"slow":[39],"reduction":[40,295,308,391],"tumour":[42,185,297,393],"size.":[43],"study":[45],"was":[46,108,147,160,169,178,217,255,272,283],"planned":[47],"to":[48,121,248,416,419],"assess":[49],"the":[50,131,197,262,341],"efficacy":[51,372],"safety":[53,398],"rapid":[55,365],"escalation":[56],"men":[61,67,400],"with":[62,68,183,233,401,405],"macroprolactinomas.":[63,402],"MATERIALS:":[64],"Fifteen":[65],"consecutive":[66],"macroprolactinomas":[69],"underwent":[70],"evaluation":[71],"for":[72,413],"anterior":[73],"pituitary":[74],"functions,":[75],"visual":[76,200,209,269],"fields,":[77],"quality":[78],"life":[80],"(QOL)":[81],"score":[82],"magnetic":[84],"resonance":[85],"imaging":[86],"(MRI),":[87],"at":[88,104,110,158,176,286],"baseline":[89,177],"after":[91,227,278,309,343],"6":[92,287,344],"months":[93,311],"therapy.":[96,314,356],"Serum":[97,174],"testosterone":[100,317],"levels":[101,318],"were":[102,319,350],"assessed":[103],"intervals.":[106],"Cabergoline":[107],"started":[109,326],"dosage":[112],"0.5":[114],"mg":[115,123,128,136],"twice":[116,124],"per":[117,125,150,194,205,242,259,293,301,306],"week":[118,126],"increased":[120],"1.5":[122],"(3":[127],")":[129],"by":[130,240,264],"third":[132],"week,":[133],"as":[134,140,149,373,375],"3":[135],"is":[137],"usually":[138],"considered":[139],"effective":[141],"dose.":[142],"Subsequent":[143],"increase":[144],"done":[148,418],"protocol.":[151],"RESULTS:":[152],"The":[153,211],"mean":[154,212],"age":[155],"patients":[157,198,226,263,290,324,342],"presentation":[159],"31.7":[161],"+/-":[162,171,180,189,246,250],"3.3":[163],"yr":[164],"duration":[166],"symptoms":[168],"25.0":[170],"3.6":[172],"months.":[173,288,345],"6249.3":[179,245],"3259.2":[181,247],"microg/l":[182,252],"volume":[186],"28.9":[188],"8.3":[190],"cm(3).":[191],"Eighty":[192],"six":[193,310],"cent":[195,206,243,260,294,302,307],"had":[199,207,291,303],"field":[201,270],"defects":[202,271],"while":[203],"53":[204],"decreased":[208],"acuity.":[210],"dose":[213],"required":[216],"3.2":[218],"mg/wk.":[219],"Symptoms":[220],"improved":[221],"majority":[223],"(93%)":[224],"four":[228],"weeks":[229],"therapy":[232,333],"dramatic":[235],"fall":[236],"99":[241],"from":[244,328],"46.9":[249],"14.9":[251],"it":[254],"normalized":[256],"93":[258],"8.2":[265],"wk.":[266],"Improvement":[267],"noted":[273],"all":[275],"but":[276],"one,":[277],"one":[279],"month":[280,330],"there":[282],"further":[284],"improvement":[285],"All":[289],">25":[292],"size,":[298,394],"73":[300],">":[304],"50":[305],"Basal":[315],"circulating":[316],"low":[320],"11":[322],"(73%)":[323],"improving":[327],"first":[329],"became":[335],"normal":[336],"around":[338],"half":[339],"No":[346],"major":[347],"side":[348],"effects":[349],"observed":[351],"requiring":[352],"discontinuation":[353],"INTERPRETATION":[357],"CONCLUSIONS:":[359],"Our":[360],"preliminary":[361],"findings":[362],"show":[363],"that":[364],"build-up":[366],"increases":[370],"well":[374],"rapidity":[376],"response":[378],"terms":[380],"clinical":[381],"improvement,":[382],"gonadal":[388],"functions":[389],"without":[395],"compromising":[396],"Further":[403],"studies":[404],"larger":[407],"sample":[408],"size":[409],"control":[411],"group":[412],"comparison":[414],"need":[415],"be":[417],"confirm":[420],"these":[421],"findings.":[422]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W149195136","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
